for Centralian Controls employee[.]eml

Sharing

Copy URL

Twitter E-mail

General

Target

for Centralian Controls employee.eml
Size

66KB
MD5

37e703d87e5f5f2ec2a9ede8e887e2ad
SHA1

1bfd7d029b0140cbeed1c7de57248a03b3c30e18
SHA256

be4fe12f9fd0da0bb98c978f3fb19571318c13200d3253b416147591085d6d47
SHA512

80838876beed7c0cb3c1a477209cd6f9740d17cde7f42dc8382ca801901e0ba3268dc6634d1b79032e7c798513dca14003ba84b5b2c56c20ba51fb79f8cd48d6
SSDEEP

1536:wOudBnMMYdKbbugaGMFT5VPCnGXuxPST0FP44eKYujgAeKnn:VonMMYpR/CnGXulSwFP44dYujGKn

Score

1^/10

Malware Config

Signatures

Files

for Centralian Controls employee.eml
.eml
- https://app.esign.docusign.com/e/er?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&s=566810826&lid=12141&elqTrackId=c78ee3f214bf409f9b5dccae155e30ee&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqcst=272&elqcsid=20567
- https://counsel-us.com/creativity/slugger/?a=kHjZxOuum2FIo
- https://images.esign.docusign.com/EloquaImages/clients/DocuSign/%7B16a6c318-40bd-41e0-b2ee-93b82d30f867%7D_The_DocuSign_Team_-_signature_-_graphic_%28150%29%5B2%5D.png
- https://images.esign.docusign.com/EloquaImages/clients/DocuSign/%7B10ecf386-4abc-4941-84cf-003a0700a121%7D_600x1-blank.png
- https://app.esign.docusign.com/e/er?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&s=566810826&lid=6745&elqTrackId=f1698623046747d5bceea0babffd812f&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqcst=272&elqcsid=20059
- https://app.esign.docusign.com/e/er?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&s=566810826&lid=17284&elqTrackId=ac65dde982e2428ea973ecdfa1504acc&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqcst=272&elqcsid=20059
- https://app.esign.docusign.com/e/er?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&s=566810826&lid=3547&elqTrackId=e4ec2e7f58e54d6eb0f25e3932ced522&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqcst=272&elqcsid=20059
- https://app.esign.docusign.com/e/er?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&s=566810826&lid=13213&elqTrackId=7780da7134f34f3b96b8e8391f8b7042&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqcst=272&elqcsid=20059
- https://docusign.onelink.me/1032812087/docusignmobile8?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&elqTrackId=d62b1f82ba2845408aa9d7971d43dafd&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqCampaignId=27085&elqcst=272&elqcsid=20059
- https://app.esign.docusign.com/e/er?utm_campaign=EMEA-N_OMR_PROS_RoEMEA_WebTrial30Day_2022-03_Email10&utm_medium=email&utm_source=Eloqua&elqCampaignId=27085&s=566810826&lid=8387&elqTrackId=948dd13b6cca4f3c844007814995b8a1&elq=4be1280af898477ba202a60111163c8c&elqaid=53717&elqat=1&elqcst=272&elqcsid=20064
- https://docusign.com/unsubscribe
- https://docusign.com
- https://app.esign.docusign.com/e/FooterImages/FooterImage1?elq=4be1280af898477ba202a60111163c8c&siteid=566810826
- Show all
email-html-2.txt
.html
email-plain-1.txt